Research into the financial performance of Medicare accountable care organizations (ACOs) has found that organizations benefit from having prior experience with risk-bearing contracts, but that organizations that had reduced growth in healthcare spending before joining an ACO would find it difficult to improve further and share in savings, according to Marietou Ouayogode, PhD.
Research into the financial performance of Medicare accountable care organizations (ACOs) has found that organizations benefit from having prior experience with risk-bearing contracts, but that organizations that had reduced growth in healthcare spending before joining an ACO would find it difficult to improve further and share in savings, according to Mariétou Ouayogodé, PhD, post-doctoral fellow at The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth.
Transcript
Accountable care organizations are a few years old now: what have we learned about their financial performance?
In terms of financial performance we've seen that there's a lot of variation across organizations, and what we found was that prior experience with risk-bearing contracts, although it is not a compulsory condition, it did help. And it is suggesting that organizations with such experience have greater probability of doing better in this kind of environment.
Another thing that we learned was it takes time. So some organizations were not efficient—were high spenders to start with—may take a little more time to get to the point where they achieve savings and eventually earn shared savings. And what we've learned from our analysis is that efficient organizations—those that were able to reduce the growth in healthcare spending for their attributed beneficiaries—would find it a little more difficult. If they did that prior to implementing the ACO model, once they were in the ACO, since they already reduced so much of the waste, it will be very difficult now to reduce. There's not much left to purge out. As opposed to those who had more waste at baseline.
So the model is essentially creating, in a way, more opportunities for those who had more waste at baseline to achieve savings and eventually get shared savings from Medicare.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
Legal Navigation Services Key to Addressing Disparities in Cancer Care
July 31st 2025A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH
July 30th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The August issue features a conversation with Charles N. (Chip) Kahn III, MPH, the president and CEO of the Federation of American Hospitals and a longtime member of the AJMC editorial board.
Read More